Rosenberg Leon E 4
4 · Talon Therapeutics, Inc. · Filed Apr 5, 2011
Insider Transaction Report
Form 4
Rosenberg Leon E
Director
Transactions
- Award
Stock Option (right to buy)
2011-04-01+65,000→ 65,000 totalExercise: $0.77From: 2012-04-01Exp: 2021-04-01→ Common Stock (65,000 underlying)
Holdings
- 18,750
Stock Option (right to buy)
Exercise: $0.56Exp: 2019-02-24→ Common Stock (18,750 underlying) - 10,000
Stock Option (right to buy)
Exercise: $19.00Exp: 2015-11-10→ Common Stock (10,000 underlying) - 10,000
Stock Option (right to buy)
Exercise: $27.28Exp: 2016-12-12→ Common Stock (10,000 underlying) - 18,750
Stock Option (right to buy)
Exercise: $4.48Exp: 2017-12-14→ Common Stock (18,750 underlying) - 18,750
Stock Option (right to buy)
Exercise: $0.76Exp: 2020-02-16→ Common Stock (18,750 underlying) - 5,000
Stock Option (right to buy)
Exercise: $5.32Exp: 2015-04-11→ Common Stock (5,000 underlying) - 5,000
Stock Option (right to buy)
Exercise: $6.60Exp: 2015-07-14→ Common Stock (5,000 underlying) - 250
Common Stock
- 7,050
Stock Option (right to buy)
Exercise: $6.74Exp: 2014-02-01→ Common Stock (7,050 underlying) - 8,750
Stock Option (right to buy)
Exercise: $8.16Exp: 2017-04-18→ Common Stock (8,750 underlying)
Footnotes (2)
- [F1]On 9/10/10, the Company completed a one-for-four reverse stock split. All common stock amounts and exercise prices in the filing relating to securities acquired prior to 9/10/10 have been adjusted to reflect the one-for-four reverse stock split.
- [F2]Currently exercisable.